Ann: HHI Australian Operations Results Update, page-19

First 19 Last

Share
Profile

Follow
Dumaguete22

7,636 Posts.

1089

18/10/23

09:45

Post #: 70398958
Share

Originally posted by Wedgeman7: ↑

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that it has achieved another record quarter of growth, delivering ~$7,497,891 in unaudited net revenue for the quarter ended 30 September 2023 (‘Q3 FY23’).The Q3 FY23 result represents a 265% increase on the previous corresponding period (‘PCP’) (Q3 FY22: $2.05m), and a 58% rise on last quarter net revenue (Q2 FY23: $4.74m).

Recent revenue growth also takes total unaudited net revenue for FY23 to date to $14.54m, highlighting Melodiol’s ability to streamline operations and focus on high growth revenue generating opportunities in key international markets.

Despite these brilliant results in a depressed market, the knockers and down ramping is nauseatingly moronic. Stay focused on the constant progress. Profit is closer than you think. Well done team Melodial.

Expand

rapid growth in progress and they are eager to share it with monthly updates

if people cant see how this stock is being turned around, that's their problem, the fact it has had a disgraceful past will never be shaken from it, and if it does shake the stains away it will take a long time, the name change the acquisitions the new faces its all beginning to come together.

massive volume day is close, this time next year they could be 10x this revenue quite easily if the numbers keep increasing, then a consol then the $$$ in front of the SP.

ME1 Price at posting: 0.6¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply